Chronic total occlusion percutaneous coronary intervention during the COVID-19 pandemic: Insights from the PROGRESS-CTO registry

• Evangelia Vemmou,
• Khaldoon Alaswad,
• Jaikirshan J. Khatri,
• Dmitrii Khelimskii,
• Oleg Krestyaninov,
• Paul Poommipanit,
• Judit Karacsonyi,
• Ilias Nikolakopoulos,
• Santiago Garcia,
• Emmanouil S. Brilakis

Affiliations

Evangelia Vemmou

Minneapolis Heart Institute Foundation, Minneapolis, MN, USA

Khaldoon Alaswad

Henry Ford Health System, Detroit, MI, USA

Jaikirshan J. Khatri

Cleveland Clinic, Cleveland, OH, USA

Dmitrii Khelimskii

Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia

Oleg Krestyaninov

Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia

Paul Poommipanit

University Hospitals, Case Western Reserve University, Cleveland, OH, USA

Judit Karacsonyi

Minneapolis Heart Institute Foundation, Minneapolis, MN, USA

Ilias Nikolakopoulos

Minneapolis Heart Institute Foundation, Minneapolis, MN, USA

Santiago Garcia

Minneapolis Heart Institute Foundation, Minneapolis, MN, USA; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA

Emmanouil S. Brilakis

Corresponding author. Emmanouil S. Brilakis, MD, PhD, Minneapolis Heart Institute, 920 E 28th Street #300, Minneapolis, Minnesota 55407, USA. Tel.: 612-863-3900, Fax: F: 612-863-6441.; Minneapolis Heart Institute Foundation, Minneapolis, MN, USA; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA